Product Information
RIZATRIPTAN 10 MG ODT is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.5103 per EA under NDC 57237008663. Its NADAC has been published 514 times since Oct 19, 2016.
FDA first approved this application on Jul 1, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237008663
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RIZATRIPTAN BENZOATEApproval Type
Generic (ANDA)
FDA Application
ANDA203062FDA Approved
7/1/2013
TE Code
AB
On Market Since
7/1/2013
Pharmacological Classes
Price Statistics
The NADAC for RIZATRIPTAN 10 MG ODT has been published 514 times since Oct 19, 2016, and over the history we have for it it has declined 66.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5103 per EA |
|---|---|
| All-time high | $1.5128 (Jan 11, 2017) |
| All-time low | $0.4145 (Nov 20, 2024) |
| 52-week high | $0.5835 |
| 52-week low | $0.5103 |
| Median price | $0.9124 |
| Average price | $0.8724 |
| Largest weekly change | -31.5% (Nov 20, 2024) |
| Weeks tracked | 514 |
| Tracking since | Oct 19, 2016 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 37% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RIZATRIPTAN 10 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for RIZATRIPTAN 10 MG ODT, manufactured by Rising Pharma Holdings Inc., is $0.5103 per EA (NDC 57237008663), effective Aug 19, 2026.
How has the price of RIZATRIPTAN 10 MG ODT changed over time?
Over the history we have for it, the NADAC for RIZATRIPTAN 10 MG ODT has declined 66.2%. It has been tracked across 514 weekly CMS publications since Oct 19, 2016.
What are the highest and lowest recorded NADAC prices for RIZATRIPTAN 10 MG ODT?
Since Oct 19, 2016, the NADAC for RIZATRIPTAN 10 MG ODT has ranged from a low of $0.4145 (Nov 20, 2024) to a high of $1.5128 (Jan 11, 2017), with a median of $0.9124 per EA.
Are there cheaper alternatives to RIZATRIPTAN 10 MG ODT?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RIZATRIPTAN 10 MG TABLET, is $0.3204 per EA — about 37% below RIZATRIPTAN 10 MG ODT.
Who manufactures RIZATRIPTAN 10 MG ODT?
RIZATRIPTAN 10 MG ODT (NDC 57237008663) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.